![2-(2-(3-(tert-butyl)-5-methyl-7-oxo-7H-furo[3,2-g]chromen-6-yl)acetamido)-2-phenylacetic acid structure](/static/products/102/1024010-03-4.png)
2-(2-(3-(tert-butyl)-5-methyl-7-oxo-7H-furo[3,2-g]chromen-6-yl)acetamido)-2-phenylacetic acid
TL;DR: 2-(2-(3-(tert-butyl)-5-methyl-7-oxo-7H-furo[3,2-g]chromen-6-yl)acetamido)-2-phenylacetic acid (CAS 1024010-03-4) is a chemical compound with molecular formula C26H25NO6 and molecular weight 447.17 g/mol, supplied by Kehong Biological (Henan Kehong Biological Technology Co., Ltd.) with CRO/CDMO custom synthesis services.
2-[[2-(3-tert-butyl-5-methyl-7-oxofuro[3,2-g]chromen-6-yl)acetyl]amino]-2-phenylacetic acid
Also Known As: 2-(2-(3-(tert-butyl)-5-methyl-7-oxo-7H-furo[3,2-g]chromen-6-yl)acetamido)-2-phenylacetic acid, 2-[[2-(3-tert-butyl-5-methyl-7-oxofuro[3,2-g]chromen-6-yl)acetyl]amino]-2-phenylacetic acid
| Molecular Formula | C26H25NO6 |
|---|---|
| Molecular Weight | 447.17 g/mol |
| LogP | 4.62972 |
| Topological Polar Surface Area | 109.75 Ų |
| Hydrogen Bond Donors | 2 |
| Hydrogen Bond Acceptors | 5 |
| Rotatable Bonds | 5 |
| Exact Mass | 447.16818 |
| Heavy Atoms | 33 |
| Complexity | 1422.7095 |
Chemical Identifiers
| CAS Number | 1024010-03-4 |
|---|---|
| SMILES | CC1=C(C(=O)OC2=CC3=C(C=C12)C(=CO3)C(C)(C)C)CC(=O)NC(C4=CC=CC=C4)C(=O)O |
Product Overview
2-(2-(3-(tert-butyl)-5-methyl-7-oxo-7H-furo[3,2-g]chromen-6-yl)acetamido)-2-phenylacetic acid (CAS 1024010-03-4), with molecular formula C26H25NO6 and molecular weight 447.17 g/mol. IUPAC: 2-[[2-(3-tert-butyl-5-methyl-7-oxofuro[3,2-g]chromen-6-yl)acetyl]amino]-2-phenylacetic acid.
Chemical Property Profile of 2-(2-(3-(tert-butyl)-5-methyl-7-oxo-7H-furo[3,2-g]chromen-6-yl)acetamido)-2-phenylacetic acid
Property Insights of 2-(2-(3-(tert-butyl)-5-methyl-7-oxo-7H-furo[3,2-g]chromen-6-yl)acetamido)-2-phenylacetic acid
The XLogP value of 4.62972 indicates that 2-(2-(3-(tert-butyl)-5-methyl-7-oxo-7H-furo[3,2-g]chromen-6-yl)acetamido)-2-phenylacetic acid is lipophilic (fat-soluble), which may influence its absorption, distribution, and formulation strategy. The TPSA of 109.75 Ų falls within the moderate polarity range, balancing permeability and solubility for 2-(2-(3-(tert-butyl)-5-methyl-7-oxo-7H-furo[3,2-g]chromen-6-yl)acetamido)-2-phenylacetic acid. Following Lipinski's Rule of Five, 2-(2-(3-(tert-butyl)-5-methyl-7-oxo-7H-furo[3,2-g]chromen-6-yl)acetamido)-2-phenylacetic acid has 2 hydrogen bond donor(s) and 5 hydrogen bond acceptor(s), all within the drug-like range, suggesting favorable oral bioavailability potential.
Frequently Asked Questions
Frequently Asked Questions
What is the CAS number of 2-(2-(3-(tert-butyl)-5-methyl-7-oxo-7H-furo[3,2-g]chromen-6-yl)acetamido)-2-phenylacetic acid?
The CAS number of 2-(2-(3-(tert-butyl)-5-methyl-7-oxo-7H-furo[3,2-g]chromen-6-yl)acetamido)-2-phenylacetic acid is 1024010-03-4.
What is the molecular formula of 2-(2-(3-(tert-butyl)-5-methyl-7-oxo-7H-furo[3,2-g]chromen-6-yl)acetamido)-2-phenylacetic acid?
The molecular formula of 2-(2-(3-(tert-butyl)-5-methyl-7-oxo-7H-furo[3,2-g]chromen-6-yl)acetamido)-2-phenylacetic acid is C26H25NO6.
What is the molecular weight of 2-(2-(3-(tert-butyl)-5-methyl-7-oxo-7H-furo[3,2-g]chromen-6-yl)acetamido)-2-phenylacetic acid?
The molecular weight of 2-(2-(3-(tert-butyl)-5-methyl-7-oxo-7H-furo[3,2-g]chromen-6-yl)acetamido)-2-phenylacetic acid is 447.17 g/mol.
Where can I buy 2-(2-(3-(tert-butyl)-5-methyl-7-oxo-7H-furo[3,2-g]chromen-6-yl)acetamido)-2-phenylacetic acid?
You can request a quote for 2-(2-(3-(tert-butyl)-5-methyl-7-oxo-7H-furo[3,2-g]chromen-6-yl)acetamido)-2-phenylacetic acid directly from KEHONG BIO. Contact us or email info@kehongbio.com for pricing and availability.
Does KEHONG BIO offer custom synthesis for 2-(2-(3-(tert-butyl)-5-methyl-7-oxo-7H-furo[3,2-g]chromen-6-yl)acetamido)-2-phenylacetic acid?
Yes, KEHONG BIO provides custom synthesis services for 2-(2-(3-(tert-butyl)-5-methyl-7-oxo-7H-furo[3,2-g]chromen-6-yl)acetamido)-2-phenylacetic acid and related compounds. Contact us with your specific requirements including quantity, purity, and timeline.